Modulight provides a versatile and comprehensive product family for in-vitro and in-vivo illumination. Modulight lasers are used in many cell research laboratories worldwide to study photodynamic therapy (PDT). PDT utilizes photosensitizers that can be activated with specifically designed light sources – reactive oxygen is created at the target due to light activation.
Photosensitizers are also used in targeted drug delivery, and light activation is used for releasing the drug from the cargo. The PDT is on the verge of bringing another revolutionizing tool to be used in the treatment of glioblastoma, uveal melanoma, bile duct, pancreatic, and many other cancers.
Modulight’s in-vitro and in-vivo product family enables illumination of anything. We make lasers with variety of wavelengths, ranging from 400 to 2000 nm. Thus, we can support the research of all existing photosensitizers.
Modern pharmaceutical studies and life science research often incorporate photoreactive components. In-vitro studies of biomedical and pharmaceutical substances require controlled and repeatable illumination. Scientists need to accurately define the illumination parameters.
Modulight customers are using our in-vitro products as their everyday tools helping with their research. Read an application note about in-vitro cell viability and dose escalation study done for a cancer cell line.
Product offering for in-vitro
ML8500 – automated biomedical illumination device – provides targeted illumination for microplates. Each well is automatically and sequentially illuminated with a specific dose, irradiance and wavelength. Environmental parameters, like carbon dioxide content and temperature, can be adjusted. Optional fluorescence monitoring and cell imaging are also available. ML8500 supports various microplates (24/96/384/1536) and petri dishes. Illumination programs can be created remotely, and collecting data from the cloud can be conveniently done from the office – no need to control the illumination at the lab. Cloud connection enables also the remote support, service, and upgrades.
ML7710 is the most versatile oncology laser system for PDT studies, and the same product can be used for in-vitro/vivo studies and clinical therapies (CE mark, FDA approval for some combination therapies). The ML7710 is a cost-effective solution for long-term study plan including pre-clinical and clinical phases – using the same device from first phase studies to clinical tests makes regulatory work faster. The ML7710 is used already in many clinics and in well-known cancer centers worldwide. We provide internet connectivity, remote diagnostics, cloud services, and low-cost upgrades.
ML6500 and ML6600 – laser source modules with 1–3 wavelengths. ML6500 enables the use of one wavelength and ML6600 up to 3 wavelengths. These laser sources can be used together with different light delivery options, e.g., SMA connected fiber with a frontal diffuser at the end. Most popular option among in vitro studies is to have our MLAKIT sample stage that enables illumination of the well plate. Modulight provides many different sample stage designs which can be customized to fit any illumination target. We provide support for dose calculation and calibration, and our lasers have simple graphical user interfaces or they can be controlled from the computer. Products are supported with full suite of services from calibration to on-site training.
Illumination solution can be customized to your needs:
- Wavelength can be selected between 400 – 2000 nm
- Irradiance can be adjusted
- Different sample stages supporting the use of microplates, petri dishes, and possibility for customized
- Handheld piece enables in vivo subcutaneous illumination, option for spot size adjustment
- We provide many different medical fiber options
- Controlled and repeatable illumination, support for dose calculation
- Possibility to use 1-8 different wavelengths
- Pulsing possible in ms – µs range
- On-site training
- Regular calibrations and device support
In-vitro and in-vivo customer referrals
Sherri McFarland, PhD, Professor at The University of North Carolina at Greensboro
Poul Martin Bendix, PhD, Associate Professor at Niels Bohr Institute